This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14-15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 4 min This content is machine translated New secondary analysis Ginkgo biloba alleviated mild neurocognitive deficits The conclusion of a review published in the journal Neuropsychiatric Disease and Treatment in 2023 was that a proprietary Ginkgo biloba special extract led to improvements in various cognitive and…
View Post 4 min This content is machine translated Rare diseases: hATTR amyloidosis What treatment options are available today? Transthyretin-associated amyloidosis (ATTR) is hereditary (hATTR) or acquired (wATTR). In patients with unclear left ventricular hypertrophy and characteristic findings, it is recommended to investigate the presence of cardiac amyloidosis. In…
View Post 3 min This content is machine translated Restless Legs Syndrome When restless legs make life difficult Restless legs syndrome is a disorder of the nervous system that causes restlessness of movement and discomfort in the legs, which mainly occurs in the evening and at night and…
View Post 5 min This content is machine translated Diabetic neuropathy and retinopathy How risky are SGLT2i and GLP1-RA? Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP1-RA) play an important role in diabetes therapy. However, their effect on diabetic neuropathy and retinopathy is not clear.…
View Post 6 min This content is machine translated Neuroimmunology Multiple sclerosis and NMOSD: background and developments Multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) are both diseases of the central nervous system. They can have similar symptoms and for a long time NMOSD was regarded…
View Post 19 min This content is machine translated Headache treatment The therapy of migraine Migraine is one of the most common neurological disorders with a global prevalence estimated at 14–15%. The highest prevalence is between the ages of 35 and 39, and women are… CME-Test
View Post 4 min This content is machine translated Multiple sclerosis Effective treatment options developed further In most cases, multiple sclerosis is relapsing-remitting and can progress to a chronic progressive stage over time. Which therapy management is used depends on the individual circumstances as well as…
View Post 3 min This content is machine translated Neurorehabilitation Modern therapy management under discussion The joint annual conference of the German Society for Neurorehabilitation (DGNR) e. V. with the two specialist societies from Austria (OeGNR) and Switzerland (SGNR) came to a successful conclusion at…
View Post 6 min This content is machine translated Movement disorders Everything but Parkinson’s: Current findings on movement disorders The world of movement disorders is broadly diversified and is one of the most common diseases in neurology. The underlying cause is often a disorder of the basal ganglia, but…
View Post 4 min This content is machine translated Parkinson's Individualized therapy concepts for a better quality of life Parkinson’s is the second most common neurodegenerative disease. In Switzerland, around 15,000 people are affected – and the trend is rising. Movement disorders such as tremor, rigor or bradykinesia are…
